Events Conferences Webinars

The ASM Biothreats 2020 meeting will promote discussions on the latest developments and emerging technologies in the fields of biodefense, biosecurity, and biological threats. This year's meeting will feature a strong focus on high consequence pathogen research.

In this webinar ATCC expert Kevin Grady will cover these key points:

• Toxicologists need the high biological relevance of primary cells and the proliferative capacity of cell lines for standard, predictive assays; neither model provides both characteristics.
• upcyte^® technology offers sufficient quantities of hepatocytes that exhibit primary cell physiologies such as CYP activity. Long-term culturing is possible to detect low level hepatotoxicity.
• upcyte^® Hepatocytes are fully characterized with validated performance data, and they are tested for CYP induction and inhibition.

This first part of a two-part webinar series on antimicrobial resistance, presented by ATCC Scientist Christine Fedorchuk, will provide these key takeaways:

• Understanding the true burden of antimicrobial resistant infections: explaining the global prevalence and epidemiology of drug-resistant infections, breaking down morbidity and mortality of the most critical pathogens, and underlining the astronomical costs and unsustainable toll that AMR infections take.
• Explaining how drug resistance works: demonstrating how antibiotics and other antimicrobial compounds work, the molecular mechanisms employed by AMR pathogens to evade these drugs, and how resistance continues to spread.

Symposium that brings together researchers from Israeli universities, research institutes, and hospitals for updates on cutting-edge data related to all the disciplines of Biology and Translational Medicine research.

This second part of a two-part webinar series on antimicrobial resistance, presented by ATCC Scientist Christine Fedorchuk, will provide these key takeaways:

• Understanding the nature of the problem: explaining the biggest challenges hindering advancement such as financial deficits, implementation of surveillance or new therapies, and the speed of resistance outpacing the speed of scientific research.
• Explaining progress: scientific and clinical advances, how organizations are contributing to the fight against AMR, and how ATCC is contributing to the fight against AMR.

Toxicologists and scientists from related disciplines are invited to attend the SOT 59th Annual Meeting and ToxExpo in Anaheim, California. This year's program will include 60+ scientific sessions and numerous opportunities for networking and professional development.

Join the 6th Microbiome R&D and Business Collaboration Congress to learn more about the latest discoveries and development trends in microbiome research and to explore effective business and commercialization strategies that translate findings into viable products through collaborative partnerships and funding opportunities.

Join ATCC and your colleagues in the biotech community at the "Trends in Cancer Models” forum to discover the latest advancements in preclinical cancer model development. This event will feature in-depth scientific discussions and poster presentations covering essential topics such as the development of three-dimensional culture systems, best practices for organoid production, and the use of organs on a chip to mimic cancer processes ex vivo.

At the 30th European Congress of Clinical Microbiology and Infectious Diseases, the world’s leading experts will join the most important congress in infectious diseases, infection control, and clinical microbiology to present and discuss the latest results.

The Annual Translational Microbiome Conference brings together the top companies in the microbiome space working to successfully commercialize microbiome-based diagnostics, therapeutics, adjunct therapies, and direct-to-consumer services and products.